Inventor · disambiguated record
Zhulun Wang
Also filed as: WANG ZHULUN
24 granted patents·20 pending applications·210 citations·filing 2002–2025
96Inventor score
Top patents by PatentIndex Score
44 records- 0193US8324160B2Chimeric polypeptides and uses thereofLI YANG·Filed 2010·Granted Dec 4, 2012·38 cites·12 claims
- 0293US7132438B2Benzimidazole derivativesAMGEN INC·Filed 2002·Granted Nov 7, 2006·62 cites·29 claims
- 0392US9862752B2Growth differentiation factor 15 (GDF-15) constructsAMGEN INC·Filed 2014·Granted Jan 9, 2018·16 cites·27 claims
- 0492US9714276B2Growth differentiation factor 15 (GDF-15) polypeptidesAMGEN INC·Filed 2013·Granted Jul 25, 2017·17 cites·18 claims
- 0591US11891435B2Polynucleotides encoding monoclonal antibodies binding to human pituitary adenylate cyclase-activating polypeptide type I receptor (PAC1) and methods of making thereofAMGEN INC·Filed 2021·Granted Feb 6, 2024·1 cites·24 claims
- 0691US11541103B2Interleukin-21 mutein/ anti-PD-1 antibody conjugatesAMGEN INC·Filed 2018·Granted Jan 3, 2023·7 cites·34 claims
- 0791US10738110B2PAC1 antibodies and uses thereofAMGEN INC·Filed 2019·Granted Aug 11, 2020·3 cites·17 claims
- 0891US10336798B2Growth differentiation factor 15 (GDF-15) polypeptidesAMGEN INC·Filed 2017·Granted Jul 2, 2019·9 cites·21 claims
- 0991US10294303B2Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonistsAMGEN INC·Filed 2016·Granted May 21, 2019·12 cites·14 claims
- 1090US10894814B2Growth differentiation factor 15 (GDF-15) constructsAMGEN INC·Filed 2017·Granted Jan 19, 2021·4 cites·25 claims
- 1190US9382318B2ST2 antigen binding proteinsAMGEN INC·Filed 2013·Granted Jul 5, 2016·10 cites·29 claims
- 1288US11059895B2ST2 antigen binding proteinsAMGEN INC·Filed 2019·Granted Jul 13, 2021·2 cites·38 claims
- 1388US2024368292A1St2 antigen binding proteinsAMGEN INC·Filed 2024·Application pending·0 cites
- 1487US11518808B2Anti-PD-1 antibodies and methods of treatmentAMGEN INC·Filed 2019·Granted Dec 6, 2022·5 cites·21 claims
- 1587US9982054B2ST2 antigen binding proteinsAMGEN INC·Filed 2016·Granted May 29, 2018·4 cites·34 claims
- 1686US12252540B2Nucleic acid molecules encoding binding proteins for gastric inhibitory peptide receptor (GIPR)AMGEN INC·Filed 2021·Granted Mar 18, 2025·1 cites·5 claims
- 1786US11046774B2Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonistsAMGEN INC·Filed 2019·Granted Jun 29, 2021·5 cites·18 claims
- 1885US11248043B2Methods for treating a headache condition using anti-human PAC1 antibodies or antigen-binding fragments thereofAMGEN INC·Filed 2020·Granted Feb 15, 2022·1 cites·33 claims
- 1984US11739131B2Growth differentiation factor 15 (GDF-15) polypeptidesAMGEN INC·Filed 2019·Granted Aug 29, 2023·1 cites·6 claims
- 2084US10465009B2BCMA antigen binding proteinsAMGEN INC·Filed 2013·Granted Nov 5, 2019·9 cites·23 claims
- 2184US2024368236A1Growth differentiation factor 15 (gdf-15) constructsAMGEN INC·Filed 2024·Application pending·0 cites
- 2281US2024150448A1Pac1 antibodies and uses thereofAMGEN INC·Filed 2023·Application pending·0 cites
- 2380US7635774B2Benzimidazole derivativesAMGEN INC·Filed 2006·Granted Dec 22, 2009·3 cites·1 claims
- 2478US11965029B2ST2 antigen binding proteinsAMGEN INC·Filed 2021·Granted Apr 23, 2024·0 cites·36 claims
- 2571US2025376529A1Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (gipr) in combination with glp-1 agonistsAMGEN INC·Filed 2025·Application pending·0 cites
- 2670US2021079051A1Growth differentiation factor 15 (gdf-15) constructsAMGEN INC·Filed 2020·Application pending·0 cites
- 2768US2023381276A1Interleukin-21 mutein/ anti-pd-1 antibody conjugatesAMGEN INC·Filed 2022·Application pending·0 cites
- 2866US2025250313A1Il-15 agonists for cancerREMEGEN CO LTD·Filed 2024·Application pending·0 cites
- 2964US10227414B2ST2 antigen binding proteinsAMGEN INC·Filed 2017·Granted Mar 12, 2019·0 cites·45 claims
- 3063US2010048565A1Benzimidazole derivativesFRENKEL ALEXANDER DAVID·Filed 2009·Application pending·0 cites
- 3159US12435149B2Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonistsAMGEN INC·Filed 2018·Granted Oct 7, 2025·0 cites·49 claims
- 3255US2022402985A1ENGINEERED NRG-1 VARIANTS WITH IMPROVED SELECTIVITY TOWARD ErbB4 BUT NOT AGAINST ErbB3AMGEN INC·Filed 2022·Application pending·0 cites
- 3353US2024182600A1Balanced Charge Distribution in Electrostatic Steering of Chain Pairing in Multi-specific and Monovalent IgG Molecule AssemblyAMGEN INC·Filed 2022·Application pending·0 cites
- 3453US2024002545A1Novel linkers of multispecific antigen binding domainsAMGEN INC·Filed 2021·Application pending·0 cites
- 3551US2023374162A1Rational selection of building blocks for the assembly of multispecific antibodiesAMGEN INC·Filed 2021·Application pending·0 cites
- 3651US2023322867A1Immunogens derived from sars-cov2 spike proteinAMGEN INC·Filed 2021·Application pending·0 cites
- 3751US2011086834A1Alkynyl alcohols as kinase inhibitorsAMGEN INC·Filed 2009·Application pending·0 cites
- 3850US2023322955A1Antigen binding proteins with non-canonical disulfide in fab regionAMGEN INC·Filed 2021·Application pending·0 cites
- 3949US2022363770A1Anti-cgrp receptor/anti-pac1 receptor bispecific antigen binding proteinsAMGEN INC·Filed 2020·Application pending·0 cites
- 4048US2022389119A1ENGINEERING CHARGE PAIR MUTATIONS FOR PAIRING OF HETERO-IgG MOLECULESAMGEN INC·Filed 2020·Application pending·0 cites
- 4147US2013143796A1Chimeric polypeptides and uses thereofAMGEN INC·Filed 2012·Application pending·0 cites
- 4247US2023047631A1Novel multispecific antibody formatAMGEN INC·Filed 2020·Application pending·0 cites
- 4345US2022235148A1Engineering the hinge region to drive antibody dimerizationAMGEN INC·Filed 2020·Application pending·0 cites
- 4444US8772296B2Benzamide derivatives and uses related theretoPOWERS JAY P·Filed 2007·Granted Jul 8, 2014·0 cites·23 claims
Join the waitlist — get patent alerts
Get an alert when Zhulun Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →